Using these PS19-APOE mouse and isogenic hiPSC models, in which any pathological changes are due solely to the introduction of this mutation overcoming APOE4 effects, we show that the R136S mutation robustly protects against APOE4-driven AD pathologies, and we present potential mechanisms underlying these effects. The gene discussed is APOE; the disease is Alzheimer disease.